Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.21% |
| 2 | Healthcare | 10.45% |
| 3 | Technology | 8.65% |
| 4 | Financials | 8.6% |
| 5 | Consumer Discretionary | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
CALL
Integer Holdings
ITGR
$4.26B
| $804K | ﹤0.01% |
10,000
| – | – |
|
|
NXGN
3077
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $804K | ﹤0.01% |
50,000
+30,000
| +150% | +$496K |
|
3078
Generac Holdings
GNRC
$11.6B
| $801K | ﹤0.01% |
7,962
-5,148
| -39% | -$479K |
|
3079
Starwood Property Trust
STWD
$5.9B
| $799K | ﹤0.01% |
32,128
-154,438
| -83% | -$3.78M |
|
|
RIVE
3080
DELISTED
Riverview Financial Corporation Common Stock
RIVE
| $795K | ﹤0.01% |
63,674
-27,225
| -30% | -$319K |
|
3081
CALL
Carnival Corporation Ltd
CCL
$34.2B
| $793K | ﹤0.01% |
+15,600
| New | +$697K |
|
3082
Reliance Steel & Aluminium
RS
$20B
| $792K | ﹤0.01% |
6,610
-181,227
| -96% | -$20.5M |
|
3083
PG&E
PCG
$39.5B
| $791K | ﹤0.01% |
+72,760
| New | +$623K |
|
3084
CarMax
KMX
$8.89B
| $786K | ﹤0.01% |
8,965
-70,484
| -89% | -$6.63M |
|
|
SOLN
3085
DELISTED
The Southern Company
SOLN
| $784K | ﹤0.01% |
+14,544
| New | +$770K |
|
3086
Organogenesis Holdings
ORGO
$224M
| $778K | ﹤0.01% |
+161,786
| New | +$1.03M |
|
3087
Bally's
BALY
$459M
| $777K | ﹤0.01% |
30,278
+21,457
| +243% | +$517K |
|
3088
BCE
BCE
$21.8B
| $777K | ﹤0.01% |
16,769
+3,022
| +22% | +$145K |
|
3089
Sensient Technologies
SXT
$5.69B
| $777K | ﹤0.01% |
11,758
-62,696
| -84% | -$4.01M |
|
|
RAD
3090
PUT
DELISTED
Rite Aid Corporation
RAD
| $774K | ﹤0.01% |
+50,000
| New | +$489K |
|
|
NE
3091
DELISTED
Noble Corporation
NE
| $774K | ﹤0.01% |
634,810
+546,905
| +622% | +$655K |
|
|
NUVA
3092
CALL
DELISTED
NuVasive, Inc.
NUVA
| $773K | ﹤0.01% |
10,000
-10,000
| -50% | -$706K |
|
|
NUVA
3093
PUT
DELISTED
NuVasive, Inc.
NUVA
| $773K | ﹤0.01% |
10,000
-20,000
| -67% | -$1.41M |
|
3094
Aaon
AAON
$6.44B
| $772K | ﹤0.01% |
23,432
-13,687
| -37% | -$443K |
|
3095
Coca-Cola Consolidated
COKE
$13B
| $770K | ﹤0.01% |
27,110
+5,220
| +24% | +$146K |
|
3096
Biglari Holdings Class A
BH.A
$1.22B
| $769K | ﹤0.01% |
1,282
-228
| -15% | -$120K |
|
3097
World Acceptance Corp
WRLD
$886M
| $766K | ﹤0.01% |
+8,867
| New | +$913K |
|
3098
Bristow Group
VTOL
$1.36B
| $765K | ﹤0.01% |
37,599
+24,951
| +197% | +$494K |
|
|
FPRX
3099
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $765K | ﹤0.01% |
166,713
-94,286
| -36% | -$373K |
|
|
GLIBA
3100
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $765K | ﹤0.01% |
10,801
-13,205
| -55% | -$908K |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $4.28B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.